ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

721
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
•30 Nov 2016 15:45

Korea Stock Market Monthly Recap #8 - (November 2016)

November was dominated by politics driving the capital markets both in Korea and the US. The Choi Soon Shil scandal rocked Korean politics and put...

Logo
354 Views
Share
•01 Nov 2016 23:07

Korea National Pension Fund - Commitment to Buy 1 Trillion Won Worth of Small Cap Stocks in Korea

On October 26th, The Korea National Pension Fund (KNPF) announced that it will purchase 1 trillion won worth of small-mid cap stocks on the Korean...

Logo
297 Views
Share
•01 Nov 2016 13:06

Some Actionable Ideas in the Biotechnology and Pharmaceutical Sector: October 31 Sector Update

 Acadia Pharmaceuticals Inc (ACAD US), our portfolio company announced the initiation of a phase 2 study of Nuplazid in Alzheimer's related...

•31 Oct 2016 16:11

Korea Stock Market Monthly Recap #7 - (October 2016)

The top events impacting the Korean stock market in October include the raid on Hanmi Pharm Co Ltd (128940 KS), disaster recall of Samsung...

Logo
390 Views
Share
•25 Oct 2016 12:40

Key Drivers of Asia's Healthcare Sector

From a demand perspective, Asia’s population is growing as is longevity. On the supply side, Asia’s number of doctors, nurses, hospitals and...

Share
x